Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
E. Helen Kemp, Elizabeth A. Waterman & Anthony P. Weetman. (2001) Autoimmune Aspects of Vitiligo. Autoimmunity 34:1, pages 65-77.
Read now
Read now
J. M. Dugoujon & A. Cambon-thomsen. (1995) Immunoglobulin Allotypes (GM and KM) and their Interactions with HLA Antigens in Autoimmune Diseases: A Review. Autoimmunity 22:4, pages 245-260.
Read now
Read now
Articles from other publishers (27)
Parastoo Mashreghi Moghadam, Seyed Reza Rasouli, Fatemeh Gheybi, Ehsan Karimi & Amir Hossein Sahebkar. (2023) A Comprehensive Review on Present and Future of Pharmacotherapy of Vitiligo Disease and Potential Therapeutic Strategies. Phytomedicine Plus 3:2, pages 100437.
Crossref
Crossref
Burcu BEKSAC, Hanife Guler DONMEZ, Murat CAGAN & M.sinan BEKSAC. (2023) Anti-parietal cell antibody positivity in women with poor obstetric history and skin disorders: significance of preconception counselingKötü obstetrik öyküsü ve deri hastalıkları olan kadınlarda anti-parietal hücre antikor pozitifliği: gebelik öncesi danışmanlığın önemi. Cukurova Medical Journal 48:1, pages 278-282.
Crossref
Crossref
Mitesh Dwivedi, Naresh C. Laddha & Rasheedunnisa Begum. 2022. The Immunogenetics of Dermatologic Diseases. The Immunogenetics of Dermatologic Diseases
61
103
.
M. Capredon, A. Sanchez‐Mazas, E. Guitard, H. Razafindrazaka, J. Chiaroni, B. Champion & J.‐M. Dugoujon. (2011) The Arabo‐Islamic migrations in Madagascar: first genetic study of the GM system in three Malagasy populations. International Journal of Immunogenetics 39:2, pages 161-169.
Crossref
Crossref
Concetta Aloi, Alessandro Salina, Lorenzo Pasquali, Francesca Lugani, Katia Perri, Chiara Russo, Ramona Tallone, Gian Marco Ghiggeri, Renata Lorini & Giuseppe d'Annunzio. (2012) Wolfram Syndrome: New Mutations, Different Phenotype. PLoS ONE 7:1, pages e29150.
Crossref
Crossref
P. Agretti, G. De Marco, D. Sansone, C. Betterle, G. Coco, A. Dimida, E. Ferrarini, A. Pinchera, P. Vitti & M. Tonacchera. (2014) Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor. Journal of Endocrinological Investigation 33:11, pages 784-788.
Crossref
Crossref
BN Akay, M Bozkir, Y Anadolu & S Gullu. (2010) Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey. Journal of the European Academy of Dermatology and Venereology 24:10, pages 1144-1150.
Crossref
Crossref
Rosario Calderón, Rosa Lodeiro, Tito A Varela, José Fariña, Beatriz Ambrosio, Evelyne Guitard, Antonio González-Martín & Jean M Dugoujon. (2007) GM and KM immunoglobulin allotypes in the Galician population: new insights into the peopling of the Iberian Peninsula. BMC Genetics 8:1.
Crossref
Crossref
M. Taffaro, N. Pyrsopoulos, H. Cedron, E. Cacayorin, D. Weppler, J. Moon, S. Nishida, D. Levi, T. Kato, G. Selvaggi, A. Tzakis & E. Schiff. (2007) Vitiligo Improvement in a Hepatitis C Patient After Treatment With PEG-Interferon α-2A and Ribavirin: A Case Report. Digestive Diseases and Sciences 52:12, pages 3435-3437.
Crossref
Crossref
N Rezaei, NG Gavalas, AP Weetman & EH Kemp. (2007) Autoimmunity as an aetiological factor in vitiligo. Journal of the European Academy of Dermatology and Venereology 21:7, pages 865-876.
Crossref
Crossref
Abdullah Abanmi, Fahad Al Harthi, Riyadh Al Baqami, Saleh Al Assaf, Abdulrahman Zouman, Misbahul Arfin & Mohammad Tariq. (2006) Association of HLA loci alleles and antigens in Saudi patients with vitiligo. Archives of Dermatological Research 298:7, pages 347-352.
Crossref
Crossref
Virendra N. Sehgal & Govind Srivastava. (2006) Vitiligo: Auto-immunity and immune responses. International Journal of Dermatology 45:5, pages 583-590.
Crossref
Crossref
Pamela R. Fain, Sunanda R. Babu, Dorothy C. Bennett & Richard A. Spritz. (2006) HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Research 19:1, pages 51-57.
Crossref
Crossref
HalIs Bulent Tastan, Ahmet Akar, Funda Elif Orkunoglu, Ercan Arca & Ali Inal. (2004) Association of HLA Class I Antigens and HLA Class II Alleles with Vitiligo in a Turkish Population. Pigment Cell Research 17:2, pages 181-184.
Crossref
Crossref
Katia Ongenae, Nanny Van Geel & Jean-Marie Naeyaert. (2003) Evidence for an Autoimmune Pathogenesis of Vitiligo. Pigment Cell Research 16:2, pages 90-100.
Crossref
Crossref
Renata Lorini, A. Alibrandi, L. Vitali, C. Klersy, M. Martinetti, C. Betterle, G. d’Annunzio & E. Bonifacio. (2001) Risk of Type 1 Diabetes Development in Children With Incidental Hyperglycemia. Diabetes Care 24:7, pages 1210-1216.
Crossref
Crossref
M. David Njoo & Wiete Westerhof. (2001) Vitiligo. American Journal of Clinical Dermatology 2:3, pages 167-181.
Crossref
Crossref
GianLuigi Marseglia, Amalia Alibrandi, Giuseppe d'Annunzio, Roberto Gulminetti, M.Antonietta Avanzini, Massimo Marconi, Carmine Tinelli & Renata Lorini. (2000) Long term persistence of anti-HBs protective levels in young patients with type 1 diabetes after recombinant hepatitis B vaccine. Vaccine 19:7-8, pages 680-683.
Crossref
Crossref
Adam Friedmann. 2000. HLA in Health and Disease. HLA in Health and Disease
365
386
.
Stephen O. Kovacs. (1998) Vitiligo. Journal of the American Academy of Dermatology 38:5, pages 647-668.
Crossref
Crossref
Renata Lorini, Andrea Scaramuzza, Luigia Cortona, Graziana Valenti, Giuseppe d'Annunzio & Gian Vico Melzi d'Eril. (1995) Increased urinary N-acetyl-?-glucosaminidase (NAG) excretion in young insulin-dependent diabetic patients. Diabetes Research and Clinical Practice 29:2, pages 99-105.
Crossref
Crossref
M. Maghnie, R. Lorini, L. Vitali, N. Mastricci, A. M. Carrà & F. Severi. (1995) Organ- and non-organ-specific auto-antibodies in children with hypopituitarism on growth hormone therapy. European Journal of Pediatrics 154:6, pages 450-453.
Crossref
Crossref
Kay-Fei Chan, Keng-He Kong & Mee-Leng Boey. (1995) “Great mimicry” in a patient with tetraparesis: A case report. Archives of Physical Medicine and Rehabilitation 76:4, pages 391-393.
Crossref
Crossref
R. Lorini, G. d'Annunzio, C. Montecucco, C. Montecucco, R. Caporali, L. Vitali, P. Pessino & F. Severi. (1995) Anticardiolipin antibodies in children and adolescents with insulin-dependent diabetes mellitus. European Journal of Pediatrics 154:2, pages 105-108.
Crossref
Crossref
Y-H. Song, E. Connor, Y. Li, B. Zorovich, P. Balducci & N. Maclaren. (1994) The role of tyrosinase in autoimmune vitiligo. The Lancet 344:8929, pages 1049-1052.
Crossref
Crossref
DAVID A. NORRIS, TATSUYA HORIKAWA & JOSEPH G. MORELLI. (2006) Melanocyte Destruction and Repopulation in Vitiligo. Pigment Cell Research 7:4, pages 193-203.
Crossref
Crossref
R. Lorini, A. Moretta, A. Valtorta, G. d'Annunzio, L. Cortona, L. Vitali, M. Bozzola & F. Severi. (1994) Cytotoxic activity in children with insulin-dependent diabetes mellitus. Diabetes Research and Clinical Practice 23:1, pages 37-42.
Crossref
Crossref